News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Appendix 4C & Activity Report

2022 Announcements.Financial.Regulatory

28.04.2022

Notice of ceasing to be a substantial holder

2022 Announcements . Financial . Regulatory

27.04.2022

CLINUVEL Kommuniqué II

2022 Announcements . Corporate . Newsletter

08.04.2022

Initial Director’s Interest Notice

2022 Announcements . Financial . Regulatory

07.04.2022

Chair’s Letter

2022 Announcements . Corporate

06.04.2022

CLINUVEL appoints new Non-Executive Director

2022 Announcements . Financial . Regulatory

04.04.2022

CLINUVEL Extends Employment Agreement With CEO

2022 Announcements . Clinical . News

01.04.2022

DNA Repair Communiqué II

2022 Announcements . Clinical . Newsletter

01.04.2022

CLINUVEL Communiqué II

2022 Announcements . Corporate . Newsletter

31.03.2022

First XP-V Patient Treated in CLINUVEL DNA Repair Study

2022 Announcements . Clinical . News

30.03.2022

Change of Director’s Interest Notice

2022 Announcements . Financial . Regulatory

23.03.2022

ACTH Manufacturing Update

2022 Announcements . Corporate . News

17.03.2022

Afamelanotide in stroke (AIS) – positive preliminary results

2022 Announcements . Clinical . News

15.03.2022

.

Go To Top